Senior Nurse adds to Clinical Expertise for Alcidion UK Team

Alcidion LtdA senior nurse with more than 20 years' experience in the NHS has joined smart health tech provider Alcidion in a core role as a clinical consultant primarily working with the UK team.

Katy Cain joins Alcidion from East Lancashire Hospitals NHS Trust, where she held a wide range of posts in clinical roles, most recently as a modern matron for the trust’s cardiology directorate.

Cain, who also actively supported the adoption of new technologies in her nursing positions, will maintain close relationships with clinicians in NHS hospitals, to ensure frontline requirements in the UK are proactively fed into Alcidion’s product roadmaps. She will also continue to cover shifts part-time as a nurse to support colleagues through the ongoing challenges of the coronavirus pandemic.

Commenting on her appointment, Cain said: "The modern technology that Alcidion is delivering to the NHS and the passion in the company for helping to improve patient care, turned my head. As a healthcare professional, I felt this was the first time I had seen technology that would make a big difference to clinicians and a tech company that really has clinicians at heart.

"Whether it is using clever technology so staff don't need to continuously remember hundreds of things, or to free up clinical time at one of the most pressured moments in the history of the health service, by joining Alcidion I felt I could help to make a difference.

"Doctors and nurses no longer have time to work around technology not designed for their needs. I look forward to working with the Alcidion team in the UK and with colleagues globally, in a company that provides technology built for clinicians and that wants to listen to and respond to the challenges being faced."

The move comes as Alcidion is expanding its reach in the NHS, following the formal UK launch of Miya Precision last summer as the first smart clinical asset for the NHS. The product integrates information from healthcare organisations’ current systems, uses it to automate routine tasks, care plans and pathways and overlays existing data with advanced clinical decision support to make otherwise static information clinically valuable. It also makes the most of emerging technologies such as artificial intelligence.

The company's Miya Observations and Miya Assessments modules - formerly known as Patientrack - are already used in more than 40 hospitals, where doctors and nurses have innovated with the system to improve patient safety, with significant impact on preventing patient deterioration, reducing adverse events such as cardiac arrests, and in tackling deadly conditions, including sepsis and acute kidney injury.

Malcolm Pradhan, chief medical officer for Alcidion, said: "We are really pleased to have another clinician with recent frontline experience in the NHS join our team. Katy will provide valuable insight to clinical requirements that we can use to frame our future product roadmaps."

Lynette Ousby, UK managing director for Alcidion, said: "Katy adds a great dimension to our team here in the UK and will be instrumental in helping us to listen to the needs of NHS professionals. The technologies we provide in the NHS are all about making the right thing the easiest thing to do, having been built and designed by clinicians. We do already have fantastic clinical leaders in Alcidion and Katy's role will enhance our ability to stay even more in tune with the real pressure points on the frontline of the health service."

About Alcidion

Alcidion (ASX:ALC) has a simple purpose: to transform healthcare with smart, intuitive technology solutions that meet the needs of hospital and allied healthcare, worldwide. It offers a complementary set of software products and services that create a unique offering in the global healthcare market; solutions that support interoperability, allow communication and task management, and deliver clinical decision support at the point of care to improve patient outcomes. In 2017 Alcidion acquired Oncall System and its Smartpage clinical communication system. In 2018 it acquired the Patientrack bedside patient monitoring software and MKM Health, an IT solutions and services provider. These offerings now operate under the Alcidion brand. With over 25 years of combined healthcare experience, Alcidion brings together the very best in technology and market knowledge to deliver solutions that make healthcare better for everyone.

Most Popular Now

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

Standing Up for Health Tech and SMEs: Sh…

AS the new chair of the health and social care council at techUK, Shane Tickell talked to Highland Marketing about his determination to support small and innovative companies, by having...

GPT-4 Matches Radiologists in Detecting …

Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology reports, according to research published in Radiology, a journal of the Radiological Society of North America...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

Experts Propose Specific and Suited Guid…

Current Artificial Intelligence (AI) models for cancer treatment are trained and approved only for specific intended purposes. GMAI models, in contrast, can handle a wide range of medical data including...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...